2157.HK HKSE
Lepu Biopharma Co., Ltd.
1W: +6.9%
1M: -8.0%
3M: -11.0%
YTD: -16.7%
1Y: -58.5%
3Y: -30.1%
HK$3.94 ($0.50)
-0.11 (-2.72%)
Weekly Expected Move ±8.6%
HK$3
HK$4
HK$4
HK$4
HK$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$196M
+21.7% ▲
Capital Expenditures
$62M
-49.9% ▼
5Y CAGR: -28.0%
Free Cash Flow
-$258M
+11.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$25M
+89.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$613M | -$1.0B | -$699M | -$22M | -$424M |
| Depreciation & Amort. | $84M | $95M | $95M | $103M | $100M |
| Stock-Based Comp. | $5M | $114M | $30M | $19M | $4M |
| Change in Working Capital | -$69M | $110M | $29M | -$38M | $88M |
| Other Non-Cash Items | $159M | $77M | $24M | -$312M | $35M |
| Operating Cash Flow | -$423M | -$622M | -$481M | -$251M | -$196M |
| — Investing Activities — | |||||
| Capital Expenditures | -$302M | -$213M | -$110M | -$28M | -$33M |
| Acquisitions (Net) | -$95M | -$90M | -$10M | $59M | $0 |
| Investment Purchases | -$1.7B | -$1.2B | -$52M | -$50M | $0 |
| Investment Sales | $1.3B | $1.5B | $98M | $50M | $0 |
| Other Investing | $771K | $0 | $0 | -$13M | -$29M |
| Investing Cash Flow | -$750M | -$4M | -$75M | $18M | -$62M |
| — Financing Activities — | |||||
| Net Debt Issuance | $29M | $146M | $356M | $44M | $100M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1.4B | $235M | -$64M | -$55M | -$81M |
| Financing Cash Flow | $1.4B | $380M | $1.0B | -$11M | $232M |
| Net Change in Cash | $214M | -$248M | $514M | -$243M | -$25M |
| Cash End of Period | $403M | $155M | $669M | $426M | $401M |
| Free Cash Flow | -$725M | -$835M | -$591M | -$292M | -$258M |